Y. Hasija

Multi-omics transformer integration reveals an invasive-like molecular phenotype in ductal carcinoma in situ

Even though 20–30% of cases of ductal carcinoma in situ (DCIS) advance to invasive breast cancer (IBC), cancer histology is unable to accurately differentiate between progressing and indolent disease. An integrated model describing the transcriptomic, epigenetic, and immunological factors influencing this shift has n...